Chromatin Organization Governs Transcriptional Response and Plasticity of Cancer Stem Cells
Authors:
Open Access
- 7 March 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (17) , e2407426
Abstract
Chromatin organization regulates transcription to influence cellular plasticity and cell fate. We explored whether chromatin nanoscale packing domains are involved in stemness and response to chemotherapy. Using an optical spectroscopic nanosensing technology we show that ovarian cancer‐derived cancer stem cells (CSCs) display upregulation of nanoscale chromatin packing domains compared to non‐CSCs. Cleavage under targets and tagmentation (CUT&Tag) sequencing with antibodies for repressive H3K27me3 and active H3K4me3 and H3K27ac marks mapped chromatin regions associated with differentially expressed genes. More poised genes marked by both H3K4me3 and H3K27me3 were identified in CSCs vs. non‐CSCs, supporting increased transcriptional plasticity of CSCs. Pathways related to Wnt signaling and cytokine‐cytokine receptor interaction were repressed in non‐CSCs, while retinol metabolism and antioxidant response were activated in CSCs. Comparative transcriptomic analyses showed higher intercellular transcriptional heterogeneity at baseline in CSCs. In response to cisplatin, genes with low baseline expression levels underwent the highest upregulation in CSCs, demonstrating transcriptional plasticity under stress. Epigenome targeting drugs downregulated chromatin packing domains and promoted cellular differentiation. A disruptor of telomeric silencing 1‐like (Dot1L) inhibitor blocked transcriptional plasticity, reversing stemness. These findings support that CSCs harbor upregulated chromatin packing domains, contributing to transcriptional and cell plasticity that epigenome modifiers can target.Keywords
Funding Information
- National Institutes of Health
- National Cancer Institute (T32GM142604)
- National Cancer Institute (R01CA228272)
- National Cancer Institute (T32AI083216)
- National Science Foundation (EFMA‐1830961)
- Ovarian Cancer Research Alliance
- National Science Foundation Graduate Research Fellowship Program (DGE‐1842165)
- Robert H. Lurie Comprehensive Cancer Center
- U.S. Department of Veterans Affairs (BX000792‐09A2)
- National Cancer Center (U54CA268084‐02)
This publication has 54 references indexed in Scilit:
- Nanoparticle Targeting in Chemo‐Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox BalanceAdvanced Science, 2024
- Transcription-mediated supercoiling regulates genome folding and loop formationMolecular Cell, 2021
- Correlating colorectal cancer risk with field carcinogenesis progression using partial wave spectroscopic microscopyCancer Medicine, 2018
- Measuring Nanoscale Chromatin Heterogeneity with Partial Wave Spectroscopic Microscopy2018
- Hypoxia-Mediated Epigenetic Regulation of Stemness in Brain Tumor CellsStem Cells, 2017
- Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem CellsCell Stem Cell, 2017
- Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug ToleranceCell Stem Cell, 2017
- Macromolecular Crowding as a Regulator of Gene TranscriptionBiophysical Journal, 2014
- End‐binding protein 1 (EB1) up‐regulation is an early event in colorectal carcinogenesisFEBS Letters, 2014
- Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances TumorigenicityCell, 2013